Latest Breaking News On - Nnounced sndx us87164f1057 - Page 1 : comparemela.com

WALTHAM, Mass., May 1, 2023 /PRNewswire/ Syndax Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that. | May 1, 2023

Sharon klahreSyndax pharmaceuticalsPrnewswire syndax pharmaceuticals incInternational numberSyndax pharmaceuticals incDial in numberNc stock exchangePress releaseNnounced sndx us87164f1057